THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 83 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,610,000 | -6.0% | 144,619 | +6.9% | 0.01% | -16.7% |
| Q3 2016 | $4,902,000 | +59.5% | 135,265 | -0.1% | 0.01% | +50.0% |
| Q2 2016 | $3,073,000 | +43.0% | 135,449 | +18.5% | 0.00% | +33.3% |
| Q1 2016 | $2,149,000 | +27.8% | 114,300 | +11.4% | 0.00% | +50.0% |
| Q4 2015 | $1,681,000 | +57.5% | 102,583 | +5.7% | 0.00% | +100.0% |
| Q3 2015 | $1,067,000 | -15.9% | 97,093 | -0.4% | 0.00% | -50.0% |
| Q2 2015 | $1,269,000 | +5.9% | 97,491 | +41.1% | 0.00% | 0.0% |
| Q1 2015 | $1,198,000 | +17.2% | 69,071 | +0.9% | 0.00% | +100.0% |
| Q4 2014 | $1,022,000 | -35.8% | 68,488 | -0.8% | 0.00% | -50.0% |
| Q3 2014 | $1,591,000 | -27.4% | 69,013 | +0.4% | 0.00% | -33.3% |
| Q2 2014 | $2,190,000 | – | 68,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |